Build Strategy
Build vs Buy Healthcare Software
Few decisions shape a healthcare technology roadmap more than build versus buy: do you develop custom software tailored to your workflows and differentiation, or adopt an off-the-shelf product and configure it? In healthcare, the stakes are higher than usual — compliance, clinical safety, integration with EHRs, and long lifecycles all weigh on the choice. This comparison frames build vs buy for healthcare software around control, cost, time, compliance, and where your real competitive advantage lies.
What you gain and give up with each
Buying off-the-shelf gets you to market fast, spreads compliance and maintenance across a vendor's customer base, and lowers upfront cost — but you inherit the product's limits, integration constraints, and roadmap, and you rarely differentiate on something everyone can buy. Building custom gives you exactly the workflows, integrations, and user experience you want, full ownership of the IP, and the ability to differentiate — at the cost of higher upfront investment, longer time-to-value, and responsibility for compliance and upkeep. Neither is universally right; it depends on whether the capability is core to your advantage.
The healthcare-specific factors
Healthcare raises the bar on both sides. EHR integration (FHIR, HL7 v2, vendor programs), regulatory compliance (HIPAA, UK GDPR, NHS DSP Toolkit), and clinical safety standards add cost and risk to building — but off-the-shelf products often integrate or comply only partially with your specific environment, leaving gaps you must fill anyway. A frequent middle path is to buy commodity components (infrastructure, identity, generic modules) and build the differentiated layer — the AI, the clinical workflow, the patient experience — on top.
A decision framework
Ask three questions. First, is this capability core to your competitive advantage? If yes, lean build; if it's undifferentiated plumbing, lean buy. Second, does an off-the-shelf option genuinely fit your workflows, integrations, and compliance needs without heavy customisation? If not, buying may cost more in workarounds than building. Third, what is your tolerance for time-to-market versus long-term control and IP ownership? Many successful healthcare products buy the commodity and build the differentiator — and a good engineering partner can de-risk the build side considerably.
Feature comparison
| Feature | Build (custom) | Buy (off-the-shelf) |
|---|---|---|
| Time to market | Slower (development) | Faster (configure) |
| Upfront cost | Higher | Lower |
| Long-term control | Full (you own it) | Limited (vendor roadmap) |
| Differentiation | High (tailored) | Low (commodity) |
| IP ownership | Yours | Vendor's |
| Compliance burden | Yours to build | Shared with vendor (partial) |
| Fit to your workflow | Exact | Approximate (may need workarounds) |
Which should you choose?
Core differentiating capability (e.g. your AI)
Build — it's your competitive moat and IP.
Commodity infrastructure or identity
Buy — don't reinvent undifferentiated plumbing.
Tight timeline, generic need
Buy or configure to reach market quickly.
Complex, unique clinical workflow
Build (or heavily extend) to fit exactly; off-the-shelf rarely matches.
Verdict
Build vs buy is rarely all-or-nothing in healthcare. Buy the commodity layers — infrastructure, identity, generic modules — to save time and spread compliance, and build the differentiated layer where your competitive advantage and IP live, typically the AI, the clinical workflow, and the user experience. Decide capability by capability using fit, differentiation, and time-to-market. The most successful products combine both — and a strong engineering partner makes the build side faster and lower-risk.
Frequently asked questions
Is it cheaper to buy healthcare software than build it?
Buying is usually cheaper upfront and faster to deploy, but can cost more over time through workarounds, integration gaps, licensing, and lack of differentiation. Building costs more initially but delivers exact fit and full ownership. The economics depend on how core the capability is.
What should I always build rather than buy?
Anything that is core to your competitive advantage and intellectual property — typically your AI models, differentiated clinical workflows, and signature user experience. Undifferentiated infrastructure is usually better bought.
Can I do both?
Yes, and most successful healthcare products do — buying commodity components and building the differentiated layer on top. This balances speed and compliance leverage with control and differentiation.
Weighing build vs buy for a healthcare product? We help you decide and build the differentiated layer fast. Book a discovery call.